![Eran Perry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eran Perry
Direktor/Vorstandsmitglied bei
COMPUGEN LTD.
Vermögen: 21 400 $ am 30.06.2026
Profil
Mr. Eran Perry is a Co-Founder and Board Member at Upstream Bio, Inc., a Co-Managing Director at Maruho Israel Innovation Fund and a Co-Founder at ICD Pharma Ltd. He is on the Board of Directors at Upstream Bio, Inc. and Compugen Ltd.
Mr. Perry was previously employed as a Board Member by Musli Thyropeutics Ltd., a Partner by I.H.C.V Israel Healthcare Ventures Ltd., an Associate by Mckinsey & Co. /Israel/, and a Business Analyst by Novartis AG /U.S.
Biologics Manufacturing Operation/.
He received his MBA from Columbia Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
COMPUGEN LTD. 0.01% | 18.03.2026 | 10’000 ( 0.01% ) | 21 400 $ | 30.06.2026 |
Aktive Positionen von Eran Perry
| Unternehmen | Position | Beginn |
|---|---|---|
| COMPUGEN LTD. | Direktor/Vorstandsmitglied | 01.07.2019 |
Maruho Israel Innovation Fund
 Maruho Israel Innovation Fund Financial ConglomeratesFinance Provides investment services in dermatology-related technologies | Vorstandsvorsitzender | 01.01.2018 |
ICD Pharma Ltd.
 ICD Pharma Ltd. Pharmaceuticals: OtherHealth Technology Operates as a clinical-stage pharmaceutical company that develops cannabis-based therapies for use as medical cannabis products | Gründer | 01.04.2017 |
Novartis Oncology | Vertrieb & Marketing | - |
MyBiotics Pharma Ltd.
 MyBiotics Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical stage company that discovers and develops microbiome-based products aimed at restoring microbial equilibrium for the biopharmaceutical | Direktor/Vorstandsmitglied | - |
Noon Aesthetics Ltd.
 Noon Aesthetics Ltd. Household/Personal CareConsumer Non-Durables Manufactures skin care products | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Eran Perry
| Unternehmen | Position | Ende |
|---|---|---|
| UPSTREAM BIO, INC. | Gründer | 01.06.2023 |
Musli Thyropeutics Ltd. | Direktor/Vorstandsmitglied | 01.08.2021 |
I.H.C.V Israel Healthcare Ventures Ltd.
 I.H.C.V Israel Healthcare Ventures Ltd. Investment ManagersFinance Israel Healthcare Ventures invests in companies located in the Israel. The firm targets companies operating in the fields of medical devices, biotechnology, pharmaceuticals and health IT. It provides financing for early stage capital requirements. | Private Equity Investor | 01.09.2016 |
| ░░░░░░░░ ░░░░░ ░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Eran Perry
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Compugen Ltd.
 Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
I.H.C.V Israel Healthcare Ventures Ltd.
I.H.C.V Israel Healthcare Ventures Ltd. Investment ManagersFinance Israel Healthcare Ventures invests in companies located in the Israel. The firm targets companies operating in the fields of medical devices, biotechnology, pharmaceuticals and health IT. It provides financing for early stage capital requirements. | Finance |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis AG /U.S. Biologics Manufacturing Operation/
 Novartis AG /U.S. Biologics Manufacturing Operation/ Pharmaceuticals: MajorHealth Technology Manufactures Bayer's Betaseron, a pharmaceutical product | Health Technology |
Mckinsey & Co. /Israel/ | Commercial Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MyBiotics Pharma Ltd.
MyBiotics Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical stage company that discovers and develops microbiome-based products aimed at restoring microbial equilibrium for the biopharmaceutical | Health Technology |
Musli Thyropeutics Ltd. | |
Maruho Israel Innovation Fund
Maruho Israel Innovation Fund Financial ConglomeratesFinance Provides investment services in dermatology-related technologies | Finance |
ICD Pharma Ltd.
ICD Pharma Ltd. Pharmaceuticals: OtherHealth Technology Operates as a clinical-stage pharmaceutical company that develops cannabis-based therapies for use as medical cannabis products | Health Technology |
Novartis Oncology | |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
Noon Aesthetics Ltd.
Noon Aesthetics Ltd. Household/Personal CareConsumer Non-Durables Manufactures skin care products | Consumer Non-Durables |
